Search results for " progress"

showing 10 items of 1287 documents

Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.

2018

Background: Monitoring neuronal injury remains one key challenge in early relapsing-remitting multiple sclerosis (RRMS) patients. Upon axonal damage, neurofilament – a major component of the neuro-axonal cytoskeleton – is released into the cerebrospinal fluid (CSF) and subsequently peripheral blood. Objective: To investigate the relevance of serum neurofilament light chain (sNfL) for acute and chronic axonal damage in early RRMS. Methods: sNfL levels were determined in 74 patients (63 therapy-naive) with recently diagnosed clinically isolated syndrome (CIS) or RRMS using Single Molecule Array technology. Standardized 3 T magnetic resonance imaging (MRI) was performed at baseline and 1–3 con…

AdultMalePathologymedicine.medical_specialtyNeurofilamentMultiple SclerosisNeurofilament lightIntermediate FilamentsSeverity of Illness IndexDisease activity03 medical and health sciencesYoung Adult0302 clinical medicineNeuronal damageNeurofilament ProteinsMedicineHumans030212 general & internal medicineNeuronsbusiness.industryMultiple sclerosisNeurodegenerationBrainMiddle Agedmedicine.diseaseNeurologyBiomarker (medicine)FemaleNeurology (clinical)Atrophybusiness030217 neurology & neurosurgeryClinical progressionBiomarkersMultiple sclerosis (Houndmills, Basingstoke, England)
researchProduct

CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors.

2007

A role for CXCR3, the receptor for chemokines Mig, IP-10 and interferon-inducible T cell alpha-chemoattractant, in tumour cell migration during melanoma progression has been proposed.To analyse CXCR3 expression in primary cutaneous malignant melanomas and its comparison with clinicopathological and prognostic factors.A retrospective immunohistochemical study was carried out on formalin-fixed paraffin-wax-embedded sections from 82 patients with primary invasive cutaneous melanomas, with a monoclonal antibody to CXCR3 (clone 49801.111; RD Systems). Immunoreactivity was semiquantitatively evaluated: labelling intensity (0, absent; 1, weak; 2, moderate; 3, strong) multiplied by the percentage o…

AdultMalePathologymedicine.medical_specialtyReceptors CXCR3Skin NeoplasmsCXCR3Pathology and Forensic MedicineImmunoenzyme TechniquesmedicineBiomarkers TumorHumansNeoplasm InvasivenessLymph nodeMelanomaAgedRetrospective StudiesAged 80 and overUnivariate analysisbusiness.industryMelanomaGeneral MedicineMiddle Agedmedicine.diseasePrognosisSurvival AnalysisNeoplasm Proteinsmedicine.anatomical_structureLymphatic MetastasisCutaneous melanomaDisease ProgressionImmunohistochemistryFemaleReceptors ChemokineOriginal ArticleSkin cancerbusinessImmunostainingJournal of clinical pathology
researchProduct

Different immunohistochemical levels of Hsp60 and Hsp70 in a subset of brain tumors and putative role of Hsp60 in neuroepithelial tumorigenesis

2013

In this work we analysed, by immunohistochemistry, a series of brain tumors to detect the levels and cellular distribution of Hsp60 and Hsp70. We found that Hsp60 levels were significantly higher than those of Hsp70 in neuroepithelial tumors, while levels of both molecules were not significantly different from each other in meningeal neoplasms. In particular, Hsp60 immunopositivity was present mainly at the cytoplasmic level, while Hsp70 immunopositivity was found both in the cytoplasm and in the nucleus of tumor cells. The levels of these molecules in healthy control cells were always very low. Finally, Hsp60 and Hsp70 levels did not correlate with the different types (WHO grade) of neopla…

AdultMalePathologymedicine.medical_specialtyanimal structuresHistologyAdolescentNeuroepithelial CellsBiophysicschemical and pharmacologic phenomenaBiologymedulloblastomamedicine.disease_causemeningiomacomplex mixturesHsp60 Hsp70 astrocytoma glioblastoma multiformae medulloblastoma meningiomaHsp70Meningeal NeoplasmsmedicineHumansHSP70 Heat-Shock ProteinsMeningeal NeoplasmChildastrocytomalcsh:QH301-705.5AgedAged 80 and overMedulloblastomaHsp60 Hsp70 astrocytoma glioblastoma multiformae medulloblastoma meningioma.Brain NeoplasmsBrief ReportfungiAstrocytomaChaperonin 60Cell BiologyMiddle AgedHsp60medicine.diseaseImmunohistochemistryNeoplasms NeuroepithelialNeuroepithelial cellglioblastoma multiformaelcsh:Biology (General)Tumor progressionChild PreschoolCancer cellImmunohistochemistryFemaleCarcinogenesisEuropean Journal of Histochemistry
researchProduct

Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.

2020

Background Hepatocellular adenomas (HCAs) are rare benign liver tumors. Guidelines recommend continued surveillance of patients diagnosed with HCAs, but these guidelines are mainly based on small studies or expert opinion. Purpose To analyze the long-term evolution of HCAs, including solitary and multiple lesions, and to identify predictive features of progression with MRI. Materials and Methods In a retrospective study, patients diagnosed with pathologically proven solitary or multiple HCAs between January 2004 and December 2015 were included; β-catenin-mutated HCAs and HCAs with foci of malignancy were considered to be at risk for progression. MRI examinations were analyzed, and tumor evo…

AdultMalePediatricsmedicine.medical_specialtyCarcinoma HepatocellularAdenomahepatocellular adenomaMEDLINEDiseaseliverMalignancyGastroenterology030218 nuclear medicine & medical imagingAdenoma Liver Cell03 medical and health sciencessymbols.namesakeText mining0302 clinical medicineMcNemar's testInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingFisher's exact testResponse Evaluation Criteria in Solid TumorsRetrospective Studiesbusiness.industryLiver NeoplasmsRetrospective cohort studymedicine.diseaseMagnetic Resonance ImagingTerm (time)Response Evaluation Criteria in Solid Tumors030220 oncology & carcinogenesissymbolsDisease ProgressionFemalebusinessProgressive diseaseMRIFollow-Up StudiesRadiology
researchProduct

Clinical features, disease progression and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspe…

2021

Objective: To develop a dedicated Italian chronic migraine (CM) database (IRON project) to overcome disease misconceptions, improve clinical administration, reduce patients' burden, and rationalize economic resource allotment.Background: Proper CM management requires a comprehensive appraisal of its full clinical, social, and economic complexity.Methods: In this cross-sectional study, CM patients were screened in 24 certified headache centers with face-to-face interviews. Information on sociodemographic factors, medical history, characteristics of CM, and of prior episodic migraine (EM), and healthcare resource use was gathered using a semistructured web-based questionnaire.Results: A total…

AdultMalePediatricsmedicine.medical_specialtyDatabases FactualMigraine DisordersDiseaseregistryState Medicine03 medical and health sciences0302 clinical medicineChronic MigraineSurveys and QuestionnairesHealth caremedicineHumansMass ScreeningMedical history030212 general & internal medicinedatabaseEconomic complexitybusiness.industryDisease progressionhealthcareMiddle AgedPatient Acceptance of Health CareLarge sampleCross-Sectional StudiesNeurologyItalySocioeconomic Factorseconomic burdenDisease ProgressionResource usePain ClinicsFemaleSettore MED/26 - NeurologiaNeurology (clinical)chronic migrainebusiness030217 neurology & neurosurgery
researchProduct

Age of onset of episodic and chronic cluster headache – a review of a large case series from a single headache centre

2016

Background In the largest case series of cluster headache (CH) published in the literature, age of onset varies between 29.6 and 31.6 years. Differences in onset age based on gender and subtype diagnosis are reported, while there are only few data on patients with childhood and elderly onset. We therefore deemed it useful to review our own large case series of CH patients. Methods The age of onset of cluster headache was investigated in a consecutive case series of 808 patients (585 men and 223 women), including 686 (503 men and 183 women) with episodic cluster headache (ECH), 103 (66 men and 37 women) with chronic cluster headache (CCH), and 19 with an indeterminate form of CH (16 men and …

AdultMalePediatricsmedicine.medical_specialtyNeurologyAdolescentClinical NeurologyCluster Headache03 medical and health sciences0302 clinical medicineAge DistributionPredictive Value of TestsEpidemiologyMedicineHumansIn patient030212 general & internal medicineAge of OnsetSex DistributionChildAgedSeries (stratigraphy)business.industryCluster headacheInfantGeneral MedicineConsecutive case seriesMiddle Agedmedicine.diseaseAnesthesiology and Pain MedicineItalyChild PreschoolChronic DiseaseDisease ProgressionElderly onsetFemaleNeurology (clinical)Age of onsetbusiness030217 neurology & neurosurgeryBiomarkersResearch ArticleThe Journal of Headache and Pain
researchProduct

Pancreatic encephalopathy: a 7-year follow-up case report and review of the literature

2003

Pancreatic encephalopathy is a rare complication of acute pancreatitis. Clinical features include focal neurological signs and acute onset of dementia. This picture can fluctuate over time: cyclic progression with remission and relapses has been described. We present the case of a 43-year-old man who, after an acute episode of pancreatitis, experienced five relapses, with alternating focal signs. The patient has improved, but cognitive impairment persists after a 7-year follow-up.

AdultMalePediatricsmedicine.medical_specialtyNeurologyRemission SpontaneousEncephalopathyDermatologyNeuropsychological TestsDiagnosis DifferentialRecurrencemedicineHumansDementiaNeuroradiologyBrain Diseasesbusiness.industryElectrodiagnosisGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingSurgeryParesisPsychiatry and Mental healthPancreatitisAcute DiseaseAmylasesChronic DiseaseDisease ProgressionAcute pancreatitisPancreatitisAtaxiaNeurology (clinical)NeurosurgeryCognition DisordersComplicationbusinessFollow-Up StudiesNeurological Sciences
researchProduct

Risk factors for high myopia: a 22‐year follow‐up study from childhood to adulthood

2018

PURPOSE To determine the effect of the definition of high myopia on its prevalence and risk factors for high myopia. METHODS A total of 240 myopic schoolchildren (119 boys and 121 girls) at the mean age of 10.9 years (range 8.8-12.8 years) were recruited to a randomized clinical trial of myopia treatment among children from 3rd- and 5th grades of school referred for an eye examination due to poor distant vision and having no previous spectacles. Clinical follow-ups, including refraction with cycloplegia, were conducted annually at 3 years [third follow-up here = clinical follow-up 1, (n = 237)], and thereafter twice at approximately 10-year intervals [clinical follow-ups 2 (n = 179) and 3, …

AdultMalePediatricsmedicine.medical_specialtyYounger ageAdolescentgenetic structuresRefraction Ocularlaw.inventionYoung Adult03 medical and health sciences0302 clinical medicineRandomized controlled trialRisk FactorslawSurveys and QuestionnairesMyopiaPrevalencemedicineHumansChildFinlandRetrospective Studiesmedicine.diagnostic_testbusiness.industryVision TestsFollow up studiesHigh myopiaCycloplegiaGeneral MedicineOdds ratioeye diseasesOphthalmologyEyeglassesEye examinationCohortDisease Progression030221 ophthalmology & optometryFemalesense organsmedicine.symptombusiness030217 neurology & neurosurgeryFollow-Up StudiesForecastingActa Ophthalmologica
researchProduct

Leucocytosis and thrombosis at diagnosis are associated with poor survival in polycythaemia vera: a population-based study of 327 patients

2012

Three hundred and twenty-seven patients from two population-based cohorts with an established diagnosis of polycythaemia vera were studied for prognostic risk factors for survival and leukaemia in a long-term survey. The relative survival (RS) was 72% and 46% at 10 and 20 years respectively, from the time of diagnosis. Multivariate analysis identified age >70 years, white blood cell count >13 × 10(9) /l and thrombo-embolism at diagnosis as independent risk factors. Patients with two or three of these factors had a 10 year RS of 26%, compared with 59% and 84% in patients with one and no risk factors, respectively. Age and leucocyte count are the main predicting factors for survival in polycy…

AdultMalePolycythaemiamedicine.medical_specialtyLeukocytosisPopulationComorbidityKaplan-Meier EstimateLeukocyte CountYoung AdultPolycythemia veraRisk FactorsCause of DeathNeoplasmshemic and lymphatic diseasesWhite blood cellInternal medicineEpidemiologymedicineHumansRisk factoreducationPolycythemia VeraAgedProportional Hazards ModelsAged 80 and overHeart FailureSwedeneducation.field_of_studyRelative survivalProportional hazards modelbusiness.industryThrombosisHematologyMiddle AgedPrognosismedicine.diseaseSurgeryLeukemia Myeloid Acutemedicine.anatomical_structureDisease ProgressionFemaleFrancebusinessFollow-Up StudiesBritish Journal of Haematology
researchProduct

Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in pati…

2004

The aim of our study was to evaluate and compare in thyroid cancer patients the predictive value for disease progression of thyroglobulin (Tg) levels measured under thyroid-stimulating hormone (TSH) stimulation, in the postoperative period just before (131)I ablative therapy and at the time of control 6-12 mo later.Two-hundred twelve consecutive patients treated for a well-differentiated thyroid carcinoma (184 papillary, 28 follicular) with no initial distant metastases were retrospectively studied. All patients had a total or near-total thyroidectomy followed by ablation with 3.7 GBq (131)I. Tg levels were determined just before ablative therapy (Tg1) and 6-12 mo later (Tg2). Thresholds of…

AdultMalePostoperative CareAdolescentStatistics as TopicReproducibility of ResultsThyrotropin[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineMiddle AgedPrognosisSensitivity and SpecificityThyroglobulinDisease-Free Survival[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine[SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicineTreatment OutcomeDisease ProgressionHumansFemaleThyroid NeoplasmsNeoplasm Recurrence LocalRadionuclide ImagingComputingMilieux_MISCELLANEOUSAged
researchProduct